-
Sort By
-
Newest
-
Newest
-
Oldest
Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
This week’s pick tends to divide opinion; some love it and some hate it. The company is Australia’s leading investment bank, Macquarie Group. It was founded in 1969 as Hill Samuel Australia, employs over 15,000 people and according to its website, it has delivered a profit over 50 consecutive years. Macquarie was one of the…